胜肽合成市場規模、佔有率和成長分析（按產品/服務、技術、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，胜肽合成市場規模將達到 7.9112 億美元，到 2025 年將成長至 8.9397 億美元，到 2033 年將成長至 23.7657 億美元，在預測期（2026-2033 年）內複合年成長率為 13%。

受肽類藥物日益成長的需求推動，肽合成市場正經歷顯著成長。這些藥物以其作為訊號分子靶向細胞膜上特定受體並觸發重要細胞內反應的能力而聞名。與小分子藥物和生技藥品相比，這些藥物具有代謝穩定性、特異性和更高的結合親和性等優勢。這種獨特性對藥理學研究、分析方法開發和雜質分析都具有重要意義。胜肽合成需求的激增部分歸因於基於胜肽的診斷和治療方案的核准不斷增加。此外，目前正在進行大量臨床試驗，以評估胜肽在治療各種慢性疾病方面的療效，這將進一步加速市場成長。

肽合成市場促進因素

對慢性疾病精準診斷日益成長的需求，顯著推動了成像技術需求的成長，進而促進了胜肽合成市場的發展，使其估值顯著提升。生物感測器和生物標記在侵入性和非侵入性診斷方法中的應用日益普及。這一趨勢在對基於胜肽的生物感測器和生物標記的需求成長上尤為明顯，並推動了肽合成領域的重大進步。隨著醫療保健環境的不斷發展，對開發高效創新診斷工具的重視，進一步促進了該細分市場的成長。

肽合成市場限制因素

肽合成市場面臨的主要限制因素是製藥公司依賴契約製造製造商生產肽類藥物。這些契約製造主要位於生產成本較低的已開發國家。然而，這種依賴性會帶來挑戰，因為每家公司都必須遵守各種標準化和安全準則，這可能會影響整個生產過程的效率和品質。此外，嚴格的監管要求可能會限制胜肽生產的柔軟性和可擴展性，從而在肽類藥物需求不斷成長的情況下阻礙市場成長。

胜肽合成市場趨勢

受製藥業蓬勃發展的推動，肽合成市場正經歷顯著成長。研發投入的增加帶動了新型態療法研發領域的投資成長。隨著製藥公司尋求創新解決方案以滿足尚未滿足的醫療需求，對胜肽類藥物的需求激增，進而推動了對先進胜肽合成技術的投資。慢性病盛行率的上升和對個人化醫療日益成長的關注進一步強化了這一趨勢，凸顯了量身定做治療方案的必要性。這些因素共同為胜肽合成解決方案創造了強勁的市場環境，使其有望持續擴張。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 專利分析
• 價值鏈分析
• 用例分析

全球胜肽合成市場規模（依產品/服務分類）及複合年成長率（2026-2033 年）

• 試劑
  • 樹脂
  • 胺基酸
  • 耦合試劑
  • 染料和螢光標記試劑
  • 其他試劑
• 裝置
  • 胜肽合成儀
  • 層析法設備
  • 冷凍乾燥機
• 服務

全球胜肽合成市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 固相胜肽合成
• 溶液相胜肽合成
• 混合重組技術

全球胜肽合成市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• CDMO 和 CRO
• 學術和研究機構

全球胜肽合成市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

  主要企業簡介

  • MERCK KGAA
  • THERMO FISHER SCIENTIFIC
  • GENSCRIPT BIOTECH CORPORATION
  • BACHEM HOLDING AG
  • KANEKA CORPORATION
  • BIOTAGE AB
  • SYNGENE INTERNATIONAL LIMITED
  • MESA LABORATORIES, INC.
  • CEM CORPORATION
  • PROTEOGENIX
  • BIO-SYNTHESIS INC.
  • DALTON PHARMA SERVICES
  • AAPPTEC
  • VIVITIDE
  • ANYGEN CO., LTD.
  • ADVANCED CHEMTECH
  • LUXEMBOURG BIO TECHNOLOGIES LTD.
  • JPT PEPTIDE TECHNOLOGIES GMBH
  • AMBIOPHARM INC.
  • AURIGENE PHARMACEUTICAL SERVICES LTD.

結論與建議

Peptide Synthesis Market size was valued at USD 791.12 Million in 2024 and is poised to grow from USD 893.97 Million in 2025 to USD 2376.57 Million by 2033, growing at a CAGR of 13% during the forecast period (2026-2033).

The peptide synthesis market is witnessing significant growth fueled by the increasing interest in peptide-based therapeutics, which are recognized for their ability to act as signaling molecules that target specific receptors on cell membranes, triggering crucial intracellular responses. These therapeutic agents offer advantages such as improved metabolic stability, specificity, and binding affinity compared to small molecule drugs and biologics. This distinctiveness influences their pharmacological research, analytical development, and impurity analysis. A surge in demand for peptide synthesis is evident, partly due to an uptick in approvals for peptide-based diagnostic and therapeutic solutions. Additionally, the landscape is marked by a considerable number of ongoing clinical trials focused on evaluating the efficacy of peptides in treating various chronic conditions, enhancing the market's growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peptide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peptide Synthesis Market Segments Analysis

Global Peptide Synthesis Market is segmented by Product & Services, Technology, end user and region. Based on Product & Services, the market is segmented into Reagents, Equipment, Services. Based on Technology, the market is segmented into Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid & Recombinant Technology. Based on end user, the market is segmented into Pharmaceutical & Biotechnology companies, CDMOs & CROs, Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Peptide Synthesis Market

The demand for imaging technologies is significantly increasing due to the need for precise diagnosis of chronic diseases, contributing to the growth of the peptide synthesis market, which has achieved notable financial valuation. The utilization of biosensors and biomarkers for both invasive and non-invasive diagnostic methods is becoming increasingly common. This trend is particularly evident in the rising demand for peptide-based biosensors and biomarkers, which is driving substantial advancements within the peptide synthesis sector. As the healthcare landscape evolves, the emphasis on developing efficient and innovative diagnostic tools is further propelling growth in this market segment.

Restraints in the Peptide Synthesis Market

The peptide synthesis market faces constraints primarily due to the reliance of pharmaceutical companies on contract manufacturing firms for the production of peptide-based therapeutic products. These contract manufacturers are mainly located in developed economies, where production costs are lower. However, this dependency can lead to challenges, as these firms must navigate various standardization and safety guidelines, which can affect the overall efficiency and quality of the manufacturing process. Additionally, the need for compliance with stringent regulations may limit the flexibility and scalability of peptide production, potentially hindering the growth of the market as demand for peptide therapies increases.

Market Trends of the Peptide Synthesis Market

The peptide synthesis market is experiencing significant growth driven by the expanding pharmaceutical industry, where escalating R&D expenditures are increasingly allocated to the development of novel therapeutic agents. As pharmaceutical companies seek innovative solutions to address unmet medical needs, the demand for peptide-based drugs is surging, leading to heightened investment in advanced peptide synthesis technologies. This trend is further fueled by the rising prevalence of chronic diseases and the growing emphasis on personalized medicine, which underscores the need for tailored therapeutic approaches. The convergence of these factors is creating a robust landscape for peptide synthesis solutions, positioning the market for sustained expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis

Global Peptide Synthesis Market Size by Product & Service & CAGR (2026-2033)

• Reagents
  • Resins
  • Amino acids
  • Coupling Reagents
  • Dyes and Fluorescent labeling reagents
  • Other Reagents
• Equipment
  • Peptide Synthesizers
  • Chromatography Equipment
  • Lyophiizers
• Services

Global Peptide Synthesis Market Size by Technology & CAGR (2026-2033)

• Solid-Phase Peptide Synthesis
• Solution-Phase Peptide Synthesis
• Hybrid & Recombinant Technology

Global Peptide Synthesis Market Size by End User & CAGR (2026-2033)

• Pharmaceutical & Biotechnology companies
• CDMOs & CROs
• Academic & Research Institutes

Global Peptide Synthesis Market Size & CAGR (2026-2033)

• North America, (Product & Services, Technology, End User)
  • US
  • Canada
• Europe, (Product & Services, Technology, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product & Services, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product & Services, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product & Services, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• MERCK KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• THERMO FISHER SCIENTIFIC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSCRIPT BIOTECH CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BACHEM HOLDING AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KANEKA CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTAGE AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNGENE INTERNATIONAL LIMITED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MESA LABORATORIES, INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEM CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PROTEOGENIX
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIO-SYNTHESIS INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DALTON PHARMA SERVICES
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AAPPTEC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVITIDE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANYGEN CO., LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADVANCED CHEMTECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LUXEMBOURG BIO TECHNOLOGIES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JPT PEPTIDE TECHNOLOGIES GMBH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMBIOPHARM INC.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AURIGENE PHARMACEUTICAL SERVICES LTD.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation